Deferred Income Tax Liabilities, Net of HALOZYME THERAPEUTICS, INC. from 31 Dec 2021 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary: HALOZYME THERAPEUTICS, INC. quarterly Deferred Income Tax Liabilities, Net in USD history and change rate from 31 Dec 2021 to 31 Dec 2025.
HALOZYME THERAPEUTICS, INC. Deferred Income Tax Liabilities, Net for the quarter ending 31 Dec 2025 was $42,924,000.
Source SEC data: View on sec.gov

Deferred Income Tax Liabilities, Net, Quarterly (USD)

Deferred Income Tax Liabilities, Net, YoY Quarterly Change (%)

HALOZYME THERAPEUTICS, INC. Quarterly Deferred Income Tax Liabilities, Net (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$42,924,000	+$42,924,000		31 Dec 2025	10-K	17 Feb 2026	2025	FY
Q3 2025	$8,218,000	-$3,734,000	-31%	30 Sep 2025	10-Q	03 Nov 2025	2025	Q3
Q4 2024	$0	$0		31 Dec 2024	10-K	17 Feb 2026	2025	FY
Q3 2024	$11,952,000			30 Sep 2024	10-Q	31 Oct 2024	2024	Q3
Q2 2024	$13,647,000			30 Jun 2024	10-Q	06 Aug 2024	2024	Q2
Q4 2023	$0			31 Dec 2023	10-Q	31 Oct 2024	2024	Q3
Q3 2022	$28,989,000			30 Sep 2022	10-Q	08 Nov 2022	2022	Q3
Q2 2022	$3,288,000			30 Jun 2022	10-Q	09 Aug 2022	2022	Q2
Q4 2021	$0			31 Dec 2021	10-Q	08 Nov 2022	2022	Q3

* An asterisk sign (*) next to the value indicates that the value is likely invalid.